All Companies

Aleva Neurotherapeutics SA

Developing next-generation implants for Deep Brain Stimulation (DBS) therapy.

Alpex Pharma SA

Contract manufacturing and formulation of drugs and food supplements.



AM-Pharma BV

Developing alkaline phosphatase as treatment for severe inflammatory conditions



Anteis SA

Hyaluronic-based products for aesthetic medicine and other medical use (acquired by Merz Pharma).



Atlas Genetics Ltd

Developing point-of-care diagnostic devices



Cadence Pharmaceuticals, Inc.

Specialty therapeutics for hospitals (publicly listed, later acquired by Mallinckrodt) CADX)



Calypso Medical Technologies, Inc.

Tumor localisation systems (acquired by Varian)



Cameron Health, Inc.

Subcutaneous implantable cardio defibrillators (acquired by Boston Scientific)



Molecular Partners AG

Development of DARPIN based therapeutics (publicly listed: MOLN)



Neose Technologies, Inc.

Next generation biotherapeutics (asset sale to Teva and Novo Nordisk)



Natural Dental Implants AG

Minimally invasive dental implants for single tooth replacement



Neoptics AG

Intracorneal lenses for the treatment of presbyopia



Optimer Pharmaceuticals, Inc.

Anti-infective therapeutics (publicly listed, later acquired by Cubist)



Opsona Therapeutics Ltd

Developing TLR agonists for the treatment of inflammatory conditions and cancer



Orthocon, Inc. (now Abyrx, Inc.)

Surgical biomaterials



Radius Health, Inc.

Developing therapeutics for osteoporosis and other serious endocrine mediated diseases (publicly listed: RDUS).



Sonetik AG

Hearing devices



Swiss Smile AG

Dental clinics chain



TargeGen, Inc.

Small molecule kinase inhibitors to treat cancer (acquired by Sanofi)



Tioga Pharmaceuticals, Inc.

Developing therapeutics for the treatment of pruritus.



Vaximm AG

Developing cancer immuno-therapeutics